Select a community
ALS including PLS and PMA
Find out more about the PatientsLikeMe
ALS Community
Home > Community Treatment Reports > Carbidopa-Levodopa 25-100 (carbidopa-levodopa) Treatment Report
What is Carbidopa-Levodopa 25-100?

Levodopa 100 mg, a dopamine precursor used to treat the movement disorder symptoms of Parkinson's disease is combined with carbidopa 25 mg. Carbidopa is often included with levodopa-containing drugs in order to boost its efficacy by slowing down the metabolism of dopamine.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
To control Parkinsonian traits 1 0
twitches and jerks 1 1
Balance problems 1 1

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
1 100%
None
0 0%

Most commonly reported side effects

Vivid dreams
1 100%
Drowsiness
1 100%
Dizziness
1 100%
  • Mild
  • Moderate
  • Severe

Dosages

  2 x 25 mg-100 mg daily 3 x 25 mg-100 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1  

Duration See details about how long patients take this treatment ▼

Currently Taking Carbidopa-Levodopa 25-100

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
0
1
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
0 0%
Usually
1 100%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
1 100%
Not at all
0 0%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
1 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 23, 2009.